Rational Labs Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-06-2024
- Paid Up Capital ₹ 0.32 M
as on 23-06-2024
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3.98%
(FY 2020)
- Profit 14.57%
(FY 2020)
- Ebitda -39.53%
(FY 2020)
- Net Worth 28.37%
(FY 2020)
- Total Assets 16.40%
(FY 2020)
About Rational Labs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.32 M, as per Ministry of Corporate Affairs (MCA) records.
Rami Mutyala, Venkata Boilla, and Enkemi Mutyala serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PTC042324
- Company No.
042324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rational Labs Private Limited offer?
Rational Labs Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Rational Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rami Mutyala  | Director | 11-May-2013 | Current |
| Venkata Boilla | Director | 27-Jun-2011 | Current |
| Enkemi Mutyala | Director | 27-Jun-2011 | Current |
Financial Performance of Rational Labs.
Rational Labs Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.98% increase. The company also saw a substantial improvement in profitability, with a 14.57% increase in profit. The company's net worth Soared by an impressive increase of 28.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rational Labs?
In 2019, Rational Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genomik Design Pharmaceuticals Private LimitedActive 21 years 11 monthsVenkata Boilla and Enkemi Mutyala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rational Labs?
Rational Labs has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rational Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rational Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
